{"log_id": 9048618154641641217, "direction": 0, "words_result_num": 55, "words_result": [{"probability": {"variance": 0, "average": 0.999544, "min": 0.997795}, "location": {"width": 413, "top": 98, "height": 31, "left": 131}, "words": "6建议在诱导及其后治疗期间进行肝功能检查"}, {"probability": {"variance": 3e-06, "average": 0.999162, "min": 0.990553}, "location": {"width": 1010, "top": 125, "height": 45, "left": 132}, "words": "7配制的溶液应避免接触皮肤和粘膜,以及任何药物溶液吸收的可能性,建议配制溶液时戴口罩和保护手套,如"}, {"probability": {"variance": 0, "average": 0.999679, "min": 0.998791}, "location": {"width": 247, "top": 153, "height": 30, "left": 92}, "words": "果意外溅出,用水彻底冲洗"}, {"probability": {"variance": 0, "average": 0.99968, "min": 0.997741}, "location": {"width": 412, "top": 181, "height": 30, "left": 132}, "words": "8污染的物品应在保证安全的条件下予以废弃"}, {"probability": {"variance": 7e-06, "average": 0.99883, "min": 0.987105}, "location": {"width": 469, "top": 207, "height": 34, "left": 98}, "words": "【孕妇及哺乳期妇女用药】本品在孕期及哺乳期禁用"}, {"probability": {"variance": 3e-06, "average": 0.99891, "min": 0.993501}, "location": {"width": 426, "top": 231, "height": 36, "left": 100}, "words": "【儿童用药】未进行该项实验且无可靠参考文献"}, {"probability": {"variance": 2.6e-05, "average": 0.99814, "min": 0.976244}, "location": {"width": 409, "top": 259, "height": 31, "left": 116}, "words": "老年用药】未进行该项实验且无可靠参考文献"}, {"probability": {"variance": 2e-06, "average": 0.998515, "min": 0.995606}, "location": {"width": 147, "top": 285, "height": 23, "left": 103}, "words": "【药物相互作用】"}, {"probability": {"variance": 1e-06, "average": 0.999143, "min": 0.99727}, "location": {"width": 333, "top": 309, "height": 32, "left": 132}, "words": "与所有细胞毒药物有相同的相互作用"}, {"probability": {"variance": 1.2e-05, "average": 0.999166, "min": 0.975586}, "location": {"width": 1013, "top": 335, "height": 46, "left": 127}, "words": "1因为肿瘤增加了血栓的危险,通常采用抗凝血治疗。肿瘤病例中血液凝固性存在很大的个体间差异,从而增加"}, {"probability": {"variance": 2.1e-05, "average": 0.998137, "min": 0.972999}, "location": {"width": 1046, "top": 363, "height": 45, "left": 91}, "words": "了口服抗凝血剂与抗肿瘤化疗之间相互作用的不测事件。因此,如若决定患者口服抗凝血剂治疗,需要增加NR检验"}, {"probability": {"variance": 0, "average": 0.999688, "min": 0.999436}, "location": {"width": 64, "top": 393, "height": 23, "left": 89}, "words": "的次数"}, {"probability": {"variance": 2e-06, "average": 0.998357, "min": 0.995701}, "location": {"width": 142, "top": 419, "height": 25, "left": 128}, "words": "2联合用药禁忌"}, {"probability": {"variance": 4e-06, "average": 0.99869, "min": 0.991152}, "location": {"width": 959, "top": 445, "height": 43, "left": 151}, "words": "1)苯妥英(为了预防某些抗肿瘤药物诱发的惊阙时应用)应用阿霉素、柔红霉素、卡铂、顺铂、卡莫司汀"}, {"probability": {"variance": 2.6e-05, "average": 0.998248, "min": 0.966512}, "location": {"width": 954, "top": 471, "height": 46, "left": 178}, "words": "长春新碱、长春碱、博莱霉素、甲氨蝶呤时,由于细胞增殖抑制剂导致苯妥英在消化道吸收的减少,从而"}, {"probability": {"variance": 1.5e-05, "average": 0.99811, "min": 0.980234}, "location": {"width": 519, "top": 498, "height": 35, "left": 180}, "words": "诱发惊阙的发作。可短时间与抗惊厥的苯二氮卓类药合用"}, {"probability": {"variance": 5e-06, "average": 0.999089, "min": 0.989554}, "location": {"width": 421, "top": 526, "height": 29, "left": 151}, "words": "2)黄热病疫苗引致广泛致命的疫苗疾病的危险"}, {"probability": {"variance": 0.022004, "average": 0.946376, "min": 0.526827}, "location": {"width": 165, "top": 553, "height": 25, "left": 126}, "words": "3.联合用药需考虑"}, {"probability": {"variance": 1.6e-05, "average": 0.998481, "min": 0.980019}, "location": {"width": 819, "top": 579, "height": 38, "left": 147}, "words": "1)环孢菌素(阿霉素、依托泊甙);可能有过度的免疫抑制,导致淋巴组织增生的危险性"}, {"probability": {"variance": 5.5e-05, "average": 0.997699, "min": 0.953254}, "location": {"width": 817, "top": 607, "height": 39, "left": 148}, "words": "2)免疫抑制剂(由环孢菌素外推法得出);过度的免疫抑制,导致淋巴细胞增生的危险性"}, {"probability": {"variance": 1.1e-05, "average": 0.998302, "min": 0.985804}, "location": {"width": 316, "top": 635, "height": 30, "left": 126}, "words": "4本品与达卡巴嗪特定的相互作用:"}, {"probability": {"variance": 0, "average": 0.999407, "min": 0.997703}, "location": {"width": 1012, "top": 659, "height": 46, "left": 127}, "words": "当本品与大剂量的达卡巴嗪在同一天同时应用时偶尔会发生肺毒性(急性成年人呼吸窘迫综合症),注意避免此"}, {"probability": {"variance": 2.6e-05, "average": 0.995619, "min": 0.986125}, "location": {"width": 102, "top": 687, "height": 25, "left": 86}, "words": "种给药方法"}, {"probability": {"variance": 1e-06, "average": 0.999282, "min": 0.997112}, "location": {"width": 314, "top": 710, "height": 33, "left": 126}, "words": "应根据下述推荐方法进行联合用药"}, {"probability": {"variance": 0.000207, "average": 0.992756, "min": 0.960672}, "location": {"width": 111, "top": 740, "height": 23, "left": 153}, "words": "1)诱导治疗"}, {"probability": {"variance": 0.016142, "average": 0.961542, "min": 0.427236}, "location": {"width": 364, "top": 768, "height": 28, "left": 151}, "words": "福莫司汀100mg/m2天,在第1天和第8天"}, {"probability": {"variance": 0.005207, "average": 0.978874, "min": 0.652525}, "location": {"width": 425, "top": 796, "height": 32, "left": 156}, "words": "达卡巴嗪250mg/m2/天,在第15,16,17和18天"}, {"probability": {"variance": 3e-06, "average": 0.998795, "min": 0.995943}, "location": {"width": 160, "top": 827, "height": 23, "left": 154}, "words": "5周的治疗休息期"}, {"probability": {"variance": 1.3e-05, "average": 0.997847, "min": 0.989931}, "location": {"width": 117, "top": 853, "height": 24, "left": 153}, "words": "2)维持治疗"}, {"probability": {"variance": 0.001261, "average": 0.989023, "min": 0.847175}, "location": {"width": 270, "top": 882, "height": 27, "left": 155}, "words": "福莫司汀100mg/m2天,第1天"}, {"probability": {"variance": 0.008526, "average": 0.97316, "min": 0.567397}, "location": {"width": 385, "top": 911, "height": 30, "left": 154}, "words": "达卡巴嗪250mg/m3/天,在第2,3,4,5天"}, {"probability": {"variance": 0.000167, "average": 0.993795, "min": 0.964896}, "location": {"width": 107, "top": 936, "height": 24, "left": 94}, "words": "【药物过量】"}, {"probability": {"variance": 3e-06, "average": 0.999084, "min": 0.991472}, "location": {"width": 393, "top": 961, "height": 31, "left": 125}, "words": "目前尚无特效的解毒剂,需加强血液学监控"}, {"probability": {"variance": 0, "average": 0.99954, "min": 0.998538}, "location": {"width": 110, "top": 986, "height": 24, "left": 90}, "words": "【药理毒理】"}, {"probability": {"variance": 1.1e-05, "average": 0.998578, "min": 0.983053}, "location": {"width": 991, "top": 1010, "height": 43, "left": 128}, "words": "福莫司汀为亚硝基脲类中的抑制细胞增殖的抗肿瘤药物,具有烷基化和氨甲酰化活性,及实验性的广谱抗肿瘤"}, {"probability": {"variance": 0.000254, "average": 0.994058, "min": 0.918726}, "location": {"width": 1015, "top": 1035, "height": 45, "left": 81}, "words": "活性。其化学结构式含有一个丙氨酸的生物电子等配体(氨基-1-乙基磷酸),使其容易穿透细胞及通过血脑屏障"}, {"probability": {"variance": 1e-06, "average": 0.999448, "min": 0.997762}, "location": {"width": 120, "top": 1065, "height": 25, "left": 87}, "words": "【药代动力学"}, {"probability": {"variance": 7e-06, "average": 0.998588, "min": 0.985371}, "location": {"width": 993, "top": 1087, "height": 45, "left": 127}, "words": "人体静脉输注后,血浆消除动力学呈单指数或双指数消除,终末半衰期短。药物分子几乎完全被代谢。血浆蛋"}, {"probability": {"variance": 7e-06, "average": 0.998226, "min": 0.990514}, "location": {"width": 205, "top": 1115, "height": 25, "left": 81}, "words": "白结合率低(25~30%"}, {"probability": {"variance": 0, "average": 0.999649, "min": 0.998743}, "location": {"width": 248, "top": 1143, "height": 25, "left": 128}, "words": "福莫司汀可以穿过血脑屏障"}, {"probability": {"variance": 0, "average": 0.999829, "min": 0.999459}, "location": {"width": 73, "top": 1165, "height": 23, "left": 88}, "words": "【贮藏】"}, {"probability": {"variance": 0, "average": 0.999565, "min": 0.997196}, "location": {"width": 523, "top": 1192, "height": 34, "left": 125}, "words": "遮光,密闭,在2~8℃保存,新配制的溶液必须立刻使用"}, {"probability": {"variance": 0, "average": 0.999838, "min": 0.999639}, "location": {"width": 75, "top": 1217, "height": 30, "left": 84}, "words": "【包装】"}, {"probability": {"variance": 3.4e-05, "average": 0.997004, "min": 0.981812}, "location": {"width": 166, "top": 1245, "height": 25, "left": 126}, "words": "药用抗生素玻璃瓶"}, {"probability": {"variance": 2.5e-05, "average": 0.998104, "min": 0.966457}, "location": {"width": 980, "top": 1269, "height": 43, "left": 129}, "words": "每个药盒包括:1瓶粉末,其中含福莫司汀208毫克;1支安瓿溶剂,用于稀释药粉作胃肠外应用,其中含95%"}, {"probability": {"variance": 0.006087, "average": 0.981063, "min": 0.477394}, "location": {"width": 1010, "top": 1296, "height": 44, "left": 86}, "words": "VV)的乙醇3.35毫克及注射用水,总量共4毫克。配制好的溶液为4.16毫升,即4毫升溶液中含有200毫克福莫司汀"}, {"probability": {"variance": 2e-06, "average": 0.99873, "min": 0.996366}, "location": {"width": 157, "top": 1327, "height": 23, "left": 86}, "words": "【有效期】24个月"}, {"probability": {"variance": 1e-06, "average": 0.998425, "min": 0.996498}, "location": {"width": 182, "top": 1355, "height": 23, "left": 88}, "words": "【执行标准】YBH36"}, {"probability": {"variance": 2.9e-05, "average": 0.996172, "min": 0.980286}, "location": {"width": 247, "top": 1381, "height": 30, "left": 87}, "words": "【批准文号】国药准字200"}, {"probability": {"variance": 0.000437, "average": 0.990182, "min": 0.943434}, "location": {"width": 105, "top": 1410, "height": 22, "left": 85}, "words": "【生产企业】"}, {"probability": {"variance": 3.8e-05, "average": 0.997442, "min": 0.977355}, "location": {"width": 310, "top": 1432, "height": 31, "left": 120}, "words": "企业名称:天津太河制药有限公司"}, {"probability": {"variance": 0.007877, "average": 0.979974, "min": 0.538303}, "location": {"width": 506, "top": 1457, "height": 36, "left": 120}, "words": "生产地址:天津市大港区海洋石化科技园区金源路234号"}, {"probability": {"variance": 0.000876, "average": 0.983117, "min": 0.908185}, "location": {"width": 161, "top": 1488, "height": 22, "left": 118}, "words": "邮政编码:300270"}, {"probability": {"variance": 0.012239, "average": 0.915408, "min": 0.673772}, "location": {"width": 255, "top": 1510, "height": 29, "left": 118}, "words": "电话号码:02289"}, {"probability": {"variance": 0.000288, "average": 0.993879, "min": 0.926647}, "location": {"width": 225, "top": 1542, "height": 25, "left": 117}, "words": "传真号码:022-26279787"}], "language": 3}